Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study.
Eur Child Adolesc Psychiatry. 2005 Sep;14(6):297-304. doi: 10.1007/s00787-005-0467-6.
Eur Child Adolesc Psychiatry. 2005.
PMID: 16220213
Clinical Trial.
12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.
Hoare P, Remschmidt H, Medori R, Ettrich C, Rothenberger A, Santosh P, Schmit M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE.
Hoare P, et al. Among authors: tinline c.
Eur Child Adolesc Psychiatry. 2005 Sep;14(6):305-9. doi: 10.1007/s00787-005-0486-3.
Eur Child Adolesc Psychiatry. 2005.
PMID: 16220214
Clinical Trial.
Item in Clipboard
Autistic symptoms in children with attention deficit-hyperactivity disorder.
Clark T, Feehan C, Tinline C, Vostanis P.
Clark T, et al. Among authors: tinline c.
Eur Child Adolesc Psychiatry. 1999 Mar;8(1):50-5. doi: 10.1007/s007870050083.
Eur Child Adolesc Psychiatry. 1999.
PMID: 10367741
Item in Clipboard
Cite
Cite